Cell Expansion Market Worth $39.7 Billion by 2027 l CAGR 9.4%: Grand View Research, Inc.

News provided by

Jun 03, 2020, 04:35 ET

SAN FRANCISCO, June 3, 2020 /PRNewswire/ --The global cell expansion market size is expected to reach USD 39.7 billion by 2027 registering a CAGR of 9.4%, according to a new report by Grand View Research, Inc. Cell expansion techniques are increasingly employed for the development of cellular and gene therapies from a single cord blood collection. These techniques can also be used for the expansion of stored Stem Cells (SCs) for the development of cancer therapies. Therefore, significant developments in cord blood SCs expansion technologies are expected to boost market growth.

Key suggestions from the report:

Broad portfolio of automated expansion systems along with improvements in bioreactor design for large-scale bioproduction results in the lucrative growth opportunity for instruments
The microbial cells segment is expected to witness the fastest growth rate owing to the implementation of high-throughput cultivation approaches and techniques that avoid the formation of biofilms
Biopharmaceuticals segment held the largest revenue share in 2019 due to growth in the demand for biosimilars, continuous R&D investments in biomanufacturing, and rise in the number of approvals for biologics
Asia Pacific is anticipated to grow at the maximum CAGR from 2020 to 2027 due to presence of several consortiums that focus on the evolving fields in the biomedical industry
For instance, in November 2019, the Cell & Gene Therapy Asia 2019 held in Japan focused on the evolving field of SCs for their deployment in pharmaceutical discovery and cellular therapies

Read 170 page research report with ToC on "Cell Expansion Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Cell Type (Mammalian, Animal), By Application, By End Use, And Segment Forecasts, 2020 - 2027" at: https://www.grandviewresearch.com/industry-analysis/cell-expansion-market

Companies have made heavy investments for the expansion of tissue-engineered products and the development of biologics. For instance, in March 2019, Merck KGaA invested USD 168 million for the expansion of its biologics manufacturing facility in Switzerland. Such initiatives are expected to boost the demand for solutions required for biologic development, thereby leading to market growth.

Bioreactors are fundamental tools in this market. Extensive research studies related to the applications of bioreactor engineering approaches have led to the incorporation of novel culture technologies. Moreover, the combined use of automated bioreactors with the microcarrier technology leads to an efficient expansion and enrichment of the cancer SCs. As a result, these approaches have gained immense traction in this market.

Grand View Research has segmented the global cell expansion market on the basis of product, cell type, application, end use, and region:

Cell Expansion Product Outlook (Revenue, USD Million, 2016 - 2027)

Consumables

Reagents, Media, & Serum
Other Consumables

Culture Flasks and Accessories

Tissue Culture Flasks
Bioreactor Accessories
Other Culture Flasks and Accessories

Instruments

Automated Cell Expansion Systems
Cell Counters
Centrifuges
Bioreactors
Other Instruments

Cell Expansion Cell Type Outlook (Revenue, USD Million, 2016 - 2027)

Mammalian

Human

Stem Cells (SCs)

Adult SCs
Embryonic SCs
Induced Pluripotent SCs

Differentiated Cells

Animal

Microbial
Others

Cell Expansion Application Outlook (Revenue, USD Million, 2016 - 2027)

Biopharmaceuticals
Tissue Culture & Engineering
Vaccine Production
Drug Development
Gene Therapy
Cancer Research
Stem Cell Research
Others

Cell Expansion End-use Outlook (Revenue, USD Million, 2016 - 2027)

Biopharmaceutical & Biotechnology Companies
Research Institutes
Cell Banks
Others

Cell Expansion Regional Outlook (Revenue, USD Million, 2016 - 2027)

North America

U.S.
Canada

Europe

Germany
U.K.

Asia Pacific

China
Japan

Latin America

Brazil

Middle East & Africa

South Africa

List of Key Companies of Cell Expansion Market

Thermo Fisher Scientific, Inc.
GE Healthcare
Corning, Inc.
STEMCELL Technologies, Inc.
Merck KGaA
Miltenyi Biotec
Becton, Dickinson and Company
Terumo Bct, Inc.
Sartorius AG
Takara Bio, Inc.
Trinova Biochem GmbH
upcyte technologies GmbH

Find more research reports on Biotechnology Industry, by Grand View Research:

Clinical Oncology Next Generation Sequencing Market – Significant increase in the adoption of genome-focused pharmacology for cancer treatment is expected to provide growth avenues for the market.
Short-read Sequencing Market – Accelerated demand for personalized medicine and companion diagnostics is anticipated to fuel the growth.
Cell Sorting Market– Growing research in cell sorting technologies, technological advancements in cell sorters, and rising pharmaceutical & biotechnology companies are expected to drive growth.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter